Efficacy Response of Inhaled HFA-Albuterol Delivered via the Breath-Actuated Autohaler™ Inhalation Device Is Comparable to Dose in Patients with Asthma

References

• Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med 2000; 94: 496–500
   PubMed Web of Science ®Google Scholar
• McFadden ER. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol 1995; 96: 278–283
   PubMed Web of Science ®Google Scholar
• Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 1982; 63: 101–104
   Google Scholar
• Epstein SW, Manning CPR, Ashley MJ, Corey PN. Survey of the use of pressurized aerosol inhalers. Can Med Assoc 1979; 120: 813–816
   PubMed Web of Science ®Google Scholar
• Hartert V, Windom HH, Peebles RS, Freidhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996; 100: 386–394
   PubMed Web of Science ®Google Scholar
• Finlay WH, Zuberbuhler P. In vitro comparison of albuterol hydrofluoroalkane (Airomir) metered dose. J Aerosol Med 1999; 12: 285–291
   PubMedGoogle Scholar
• Wildhaber JH, Hayden MJ, Dore ND, Devadason SG, LeSouef PN. Albuterol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study. Chest 1998; 113: 186–191
   PubMed Web of Science ®Google Scholar
• Shapiro GS, Klinger NM, Ekholm BP, Colice GL. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma. J Asthma 2000; 3: 667–675
   Google Scholar
• Parameswaran KN, Inman MD, Ekholm BP, Morris MM, Summers E, O'Byrne PM, Hargreave FE. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist. Am J Respir Crit Care Med 1999; 160: 354–357
   PubMed Web of Science ®Google Scholar
• Ramsdell JW, Colice GL, Ekholm BP, Klinger NM. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ann Allergy Asthma Immunol 1998; 81: 593–599
   PubMed Web of Science ®Google Scholar
• Bronsky E, Ekholm BP, Klinger NM, Colice GL. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol. J Asthma 1999; 36: 107–114
   PubMed Web of Science ®Google Scholar
• Ramsdell JW, Klinger NM, Ekholm BP, Colice GL. Safety of long-term treatment with HFA albuterol. Chest 1999; 115: 945–951
   PubMed Web of Science ®Google Scholar
• Kleerup EC, Tashkin DP, Cline AC, Ekholm BP. Cumulative dose-response study of non-CFC propellant HFA 134a albuterol sulfate metered-dose inhaler in patients with asthma. Chest 1996; 109: 702–707
   PubMed Web of Science ®Google Scholar
• Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. Eur J Clin Pharmacol 1995; 48: 474–477
   Google Scholar
• Donnell D. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device. Eur Rev Med Pharmacol Sci 2001; 5: 7–16
   PubMedGoogle Scholar
• Marshik PL, Larsen JS, Leach CL, Halverson PC, Ekholm BP, Amies MH, Kaiser HB, Weisberg SC, Sellers JA. A novel breath actuated device (Autohaler) consistently actuates during the early phase of inspiration. J Aerosol Med 1995; 8: 187–195
   PubMedGoogle Scholar
• Woodman K, Bremner P, Burgess C, Crane J, Pearce N, Beasley R. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin 1993; 13: 61–69
   PubMed Web of Science ®Google Scholar
• Leach C. Effect of formulation parameters on Hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999; 104: S250–252
   PubMed Web of Science ®Google Scholar
• Finney DJ. A computer program for parallel line bioassays. J Pharmacol Exp Ther 1976; 198: 497–506
   PubMed Web of Science ®Google Scholar
• Dockhorn R, Vanden-Burgt JA, Ekholm BP, Donnell D, Cullen MT. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler in patients with asthma. J Allergy Clin Immunol 1995; 96: 50–56
   PubMed Web of Science ®Google Scholar
• Zureik M, Delacourt C. Evaluation of the ability of asthmatic children to use a breath-actuated pressurized inhaler. Arch Pediatr 1999; 6: 1172–1178
   PubMedGoogle Scholar
• Le Cocguic Y, Zureik M. Evaluation of the everyday use of a metered dose aerosol triggered by inhalation (the “Autohaler” system). Rev Pneumol Clin 1997; 53: 13–19
   PubMedGoogle Scholar
• Terzano C, Mannino F. Probability of particle and albuterol deposition in the respiratory tract: comparison between MDI and Autohaler. Monaldi Arch Chest Dis 1996; 51: 236–242
   PubMedGoogle Scholar